Delta Tissue — Execution
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Delta Tissue is a $55 million Wellcome Leap program developing platforms to profile tissue states and predict disease progression transitions — what the program describes as a "tissue time machine" capable of predicting future disease progression with sufficient precision to enable present-day intervention. Program Director Jason Swedlow, PhD — a chromosome segregation expert and co-founder of the…
Platform development for profiling tissue states and predicting disease progression transitions, aimed at enabling early intervention across academic, startup, and clinical settings.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility